Company: CWAN
Filing Date: 2025-03-20
Form Type: 424B3
Source: 0001193125-25-058975
Chunk: 25

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-20
Form: 424B3
Chunk 25
---
 the Special Meeting.”

| Q: | If my shares are held in “street name” by my bank, brokerage firm or other nominee, will my bank, 
 brokerage firm or other nominee vote my shares for me?                                            |

| A: | No. If your shares are held in “street name” by your bank, brokerage firm or other nominee, you must                                                                                                                                            
 direct your bank, brokerage firm or other nominee on how to vote and you will receive instructions from your bank, brokerage firm or other nominee describing how to vote your shares of Enfusion Common Stock. The availability of Internet or 
 telephonic voting will depend on the nominee’s voting process. Please check with your bank, brokerage firm or other nominee and follow the voting procedures your bank, brokerage firm or other nominee provides.                               |

Banks, brokers and other nominees that hold shares in “street name” for a beneficial owner of those shares typically have the authority to vote in their discretion on “routine” proposals when they have not received instructions from beneficial owners. However, banks, brokers and other nominees that hold shares in street name for a beneficial owner of those shares are not allowed to exercise voting discretion with respect to the approval of matters that are “non-routine”without specific instructions from the beneficial owner. “Broker non-votes”occur when shares held in street name are present at a stockholder meeting at which at least one item of business is a routine proposal, but the bank, broker or other nominee is not instructed by the beneficial owner of those shares to vote on a particular proposal for which the bank, broker or other nominee does not have discretionary voting power. The Merger Agreement Proposal and the Adjournment Proposal will be considered “non-routine”matters and therefore, it is expected that there will be no broker non-votesat the Special Meeting. Accordingly, if you do not provide your bank, brokerage firm or other nominee instructions on how to vote your shares of Enfusion Common Stock or Enfusion Class B Common Stock at the Special Meeting, your bank, brokerage firm or other nominee generally will not be permitted to vote your shares on any of the proposals at the Special Meeting. Enfusion strongly encourages you to 10

provide voting instructions to your bank, brokerage firm or other nominee so that your vote will be counted on all matters. A broker non-vote,if any, will have the same effect as a vote “AGAINST” the Merger Agreement Proposal and will not have any effect on the Adjournment Proposal (assuming a